Ambulatory Surgery Department, West China Second Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Gynecology and Obstetrics Department, West China Second Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Syst Rev. 2023 Jul 7;12(1):115. doi: 10.1186/s13643-023-02233-1.
Voiding trials are used to identify women at risk for postoperative urinary retention while performing optimal voiding trial management with minimal burden to the patient and medical service team. We performed a systematic review and meta-analysis of postoperative void trials following urogynecologic surgery to investigate (1) the optimal postoperative void trial methodology and (2) the optimal criteria for assessing void trial.
We searched PubMed, EMBASE, Cochrane Central Register of Controlled Trials, and relevant reference lists of eligible articles from inception to April 2022. We identified any randomized controlled trials (RCTs) in English that studied void trials in patients undergoing urogynecologic surgery. Study selection (title/abstract and full text), data extraction, and risk of bias assessment were conducted by two independent reviewers. Extracted study outcomes included the following: the correct passing rate, time to discharge, discharge rate without a catheter after the initial void trial, postoperative urinary tract infection, and patient satisfaction.
Void trial methodology included backfill-assisted and autofill studies (2 RCTs, n = 95). Backfill assistance was more likely to be successful than autofill (RR 2.12, 95% CI 1.29, 3.47, P = 0.00); however, no significant difference was found in the time to discharge (WMDs = - 29.11 min, 95% CI - 57.45, 1.23, P = 0.06). The criteria for passing void trial included subjective assessment of the urinary force of stream and objective assessment of the standard voiding trial (3 RCTs, n = 377). No significant differences were found in the correct passing rate (RR 0.97, 95% CI 0.93, 1.01, P = 0.14) or void trial failure rate (RR 0.78, 95% CI 0.52, 1.18, P = 0.24). Moreover, no significant differences were found in the complication rates or patient satisfaction between the two criteria.
Bladder backfilling was associated with a lower rate of catheter discharge after urogynecologic surgery. The subjective assessment of FOS is a reliable and safe method for assessing postoperative voiding because it is less invasive.
PROSPERO CRD42022313397.
排空试验用于识别术后尿潴留风险较高的女性,同时对患者和医疗服务团队进行最小的负担进行最佳排空试验管理。我们对妇科泌尿手术后的术后排空试验进行了系统评价和荟萃分析,以调查 (1) 最佳术后排空试验方法,以及 (2) 评估排空试验的最佳标准。
我们检索了 PubMed、EMBASE、Cochrane 中央对照试验注册库以及 2022 年 4 月之前符合条件的文章的相关参考文献列表。我们确定了任何在接受妇科泌尿手术的患者中研究排空试验的英语随机对照试验 (RCT)。由两名独立审查员进行研究选择 (标题/摘要和全文)、数据提取和偏倚风险评估。提取的研究结果包括以下内容:正确通过率、出院时间、初始排空试验后无导管出院率、术后尿路感染和患者满意度。
排空试验方法包括回填辅助和自动填充研究 (2 项 RCT,n=95)。回填辅助比自动填充更有可能成功 (RR 2.12,95%CI 1.29,3.47,P=0.00);然而,出院时间无显著差异 (WMDs=-29.11 分钟,95%CI-57.45,1.23,P=0.06)。排空试验通过的标准包括对尿流力的主观评估和对标准排空试验的客观评估 (3 项 RCT,n=377)。正确通过率无显著差异 (RR 0.97,95%CI 0.93,1.01,P=0.14)或排空试验失败率 (RR 0.78,95%CI 0.52,1.18,P=0.24)。此外,两种标准之间的并发症发生率或患者满意度无显著差异。
妇科泌尿手术后,膀胱回填与较低的导尿管排出率相关。FOS 的主观评估是一种可靠且安全的评估术后排尿的方法,因为它的侵入性较小。
PROSPERO CRD42022313397。